Figure 1 (Lanthanum 01)
Lanthanum Carbonate Tablet, Chewable
Product Images NDC 69097-936
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lanthanum Carbonate (NDC 69097-936). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Principal Display Panel (500 mg Tablet Bottle Package)
Principal Display Panel (750 mg Tablet Bottle Package)
Lanthanum Carbonate chewable tablets are intended to be taken immediately before meals to help with swallowing. The package should be handled with care and the user should follow the given instructions for best results. The provided identification numbers are G s5037-835.98 and NOC 6903783598 Rcon, but no further information about the product is available due to errors.*
Principal Display Panel (1000 mg Tablet Bottle Package)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
